Advances in preventive vaccine development against HTLV-1 infection: A systematic review of the last 35 years

Advances in preventive vaccine development against HTLV-1 infection: A systematic review of the last 35 years

IntroductionThe Human T-lymphotropic virus type 1 (HTLV-1) was the first described human retrovirus. It is currently estimated that around 5 to 10 million people worldwide are infected with this virus. Despite its high prevalence, there is still no preventive vaccine against the HTLV-1 infection. It...

Full description

Bibliographic Details
Main Authors: Carolina Souza Santana, Felipe de Oliveira Andrade, Greice Carolina Santos da Silva, Jéssica Oliveira de Souza Nascimento, Raissa Frazão Campos, Marta Giovanetti, Luciane Amorim Santos, Luana Leandro Gois, Luiz Carlos Júnior Alcantara, Fernanda Khouri Barreto
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Immunology
Subjects:
HTLV-1
vaccine
prevention
immunization
public health policies
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1073779/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1073779/full

Similar Items